Movatterモバイル変換


[0]ホーム

URL:


AU2002239348A1 - Pyrazolopyridine derivatives - Google Patents

Pyrazolopyridine derivatives

Info

Publication number
AU2002239348A1
AU2002239348A1AU2002239348AAU3934802AAU2002239348A1AU 2002239348 A1AU2002239348 A1AU 2002239348A1AU 2002239348 AAU2002239348 AAU 2002239348AAU 3934802 AAU3934802 AAU 3934802AAU 2002239348 A1AU2002239348 A1AU 2002239348A1
Authority
AU
Australia
Prior art keywords
pyrazolopyridine derivatives
same
pyrazolopyridine
derivatives
variables
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002239348A
Inventor
F. Leslie Boyd
Stanley D Chamberlain
Mui Cheung
Kristjan Gudmundsson
Philip Anthony Harris
Brian A Johns
David Kendall Jung
Michael Robert Peel
Connie Jo Sexton
Jennifer G. Stanford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group LtdfiledCriticalGlaxo Group Ltd
Publication of AU2002239348A1publicationCriticalpatent/AU2002239348A1/en
Abandonedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

The present invention provides compounds of formula (I): wherein all variables are as defined herein, pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.
AU2002239348A2000-12-152001-11-26Pyrazolopyridine derivativesAbandonedAU2002239348A1 (en)

Applications Claiming Priority (5)

Application NumberPriority DateFiling DateTitle
US25576300P2000-12-152000-12-15
US60/255,7632000-12-15
US27428401P2001-03-082001-03-08
US60/274,2842001-03-08
PCT/US2001/044231WO2002048148A2 (en)2000-12-152001-11-26Pyrazolopyridine derivatives

Publications (1)

Publication NumberPublication Date
AU2002239348A1true AU2002239348A1 (en)2002-06-24

Family

ID=26944940

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AU2002239348AAbandonedAU2002239348A1 (en)2000-12-152001-11-26Pyrazolopyridine derivatives

Country Status (8)

CountryLink
US (2)US7163940B2 (en)
EP (1)EP1377573B1 (en)
JP (1)JP2004515550A (en)
AT (1)ATE300541T1 (en)
AU (1)AU2002239348A1 (en)
DE (1)DE60112330T2 (en)
ES (1)ES2243579T3 (en)
WO (1)WO2002048148A2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
PE20020506A1 (en)2000-08-222002-07-09Glaxo Group Ltd PIRAZOLE DERIVATIVES FUSED AS PROTEIN KINASE INHIBITORS
AU2002239348A1 (en)2000-12-152002-06-24Glaxo Group LimitedPyrazolopyridine derivatives
ATE301653T1 (en)2000-12-152005-08-15Glaxo Group Ltd PYRAZOLOPYRIDINES
DE60201074T2 (en)2001-03-082005-09-15Smithkline Beecham Corp. pyrazolopyridine derivatives
EP1372642A1 (en)*2001-03-302004-01-02SmithKline Beecham CorporationUse of pyrazolopyridines as therapeutic compounds
WO2002078700A1 (en)2001-03-302002-10-10Smithkline Beecham CorporationPyralopyridines, process for their preparation and use as therapteutic compounds
DE60212949T2 (en)2001-04-102007-01-04Smithkline Beecham Corp. ANTIVIRAL PYRAZOLOPYRIDINE COMPOUNDS
ATE296826T1 (en)2001-04-272005-06-15Smithkline Beecham Corp PYRAZOLO(1,5)PYRIDINE DERIVATIVES
JP2005500315A (en)2001-06-212005-01-06スミスクライン ビーチャム コーポレーション Imidazo [1,2-a] pyridine derivatives for prevention and treatment of herpes virus infection
US7115617B2 (en)2001-08-222006-10-03Amgen Inc.Amino-substituted pyrimidinyl derivatives and methods of use
US6939874B2 (en)2001-08-222005-09-06Amgen Inc.Substituted pyrimidinyl derivatives and methods of use
JP2005507878A (en)*2001-09-072005-03-24スミスクライン ビーチャム コーポレーション Pyrazolo-pyridines for the treatment of herpes infections
US7244740B2 (en)2001-10-052007-07-17Smithkline Beecham CorporationImidazo-pyridine derivatives for use in the treatment of herpes viral infection
EP1453830B1 (en)2001-12-112007-09-12SmithKline Beecham CorporationPyrazolo-pyridine derivatives as antiherpes agents
ES2245772T3 (en)2002-03-072006-01-16Smithkline Beecham Corporation DERIVATIVES OF PIRAZOLOPIRIMIDINA AND PIRAZOLOTRIAZINA AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
JP2006504728A (en)*2002-10-032006-02-09スミスクライン ビーチャム コーポレーション Pyrazolopyridine derivative therapeutic compounds
WO2004087679A1 (en)*2003-04-012004-10-14Aponetics Ag2, 4, 6-trisubstituted pyrimidine derivatives useful for the treatment of neoplastic and autoimmune diseases
WO2006055245A2 (en)*2004-11-172006-05-26Smithkline Beecham CorporationProcess for preparing pyrazolopyridine compounds
JP5426878B2 (en)*2005-05-242014-02-26バーテックス ファーマシューティカルズ インコーポレイテッド ATP-binding cassette transporter modulator
UA103319C2 (en)2008-05-062013-10-10Глаксосмитклайн ЛлкThiazole- and oxazole-benzene sulfonamide compounds
EP2536410B1 (en)*2010-02-182015-09-23Merck Sharp & Dohme Corp.Substituted pyrimidine derivatives and their use in treating viral infections
EP2402336A1 (en)2010-06-292012-01-04Basf SePyrazolopyridine compounds
EP2402335A1 (en)2010-06-292012-01-04Basf SePyrazolopyridine compounds
KR20140072177A (en)*2011-10-062014-06-12바이엘 인텔렉쳐 프로퍼티 게엠베하Heterocyclylpyri(mi)dinylpyrazole
DK2922828T3 (en)2012-11-212020-08-31Ptc Therapeutics Inc 4,6-DIAMINO-PYRIMIDINE DERIVATIVES AS BMI-1 INHIBITORS TO TREAT CANCER
BR112021002630A2 (en)2018-08-172021-05-11Ptc Therapeutics, Inc. method to treat pancreatic cancer

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US46478A (en)*1865-02-21Isaac s
US3666440A (en)*1970-03-131972-05-30Mitsubishi Metal Mining Co LtdMethod of recovering copper from slag
EP0151962A3 (en)*1984-01-251985-10-02Beecham Group PlcPyrazolopyridine derivatives
GB8404586D0 (en)*1984-02-221984-03-28Beecham Group PlcCompounds
GB8404584D0 (en)*1984-02-221984-03-28Beecham Group PlcCompounds
US5002941A (en)1985-12-121991-03-26Smithkline Beecham CorporationPyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US4925849A (en)*1987-06-151990-05-15Fujisawa Pharmaceutical Company, Ltd.Pharmaceutically useful pyrazolopyridines
US5155114A (en)*1989-01-231992-10-13Fujisawa Pharmaceutical Company, Ltd.Method of treatment using pyrazolopyridine compound
GB8901423D0 (en)1989-01-231989-03-15Fujisawa Pharmaceutical CoPyrazolopyridine compound and processes for preparation thereof
WO1991000092A1 (en)1989-06-131991-01-10Smithkline Beecham CorporationInhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
AU622330B2 (en)*1989-06-231992-04-02Takeda Chemical Industries Ltd.Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
KR930700104A (en)1990-06-121993-03-13원본미기재 Inhibition of diseases mediated by the 5-lipoxygenase and cyclooxygenase pathways
GB9015764D0 (en)*1990-07-181990-09-05Fujisawa Pharmaceutical CoPyrazolopyridine compound and processes for preparation thereof
EP0497258B1 (en)1991-01-292002-01-02Fujisawa Pharmaceutical Co., Ltd.Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer
GB9107513D0 (en)*1991-04-101991-05-29Fujisawa Pharmaceutical CoPyrazolopyridine compound and processes for preparation thereof
US5300478A (en)*1993-01-281994-04-05Zeneca LimitedSubstituted fused pyrazolo compounds
US5474995A (en)1993-06-241995-12-12Merck Frosst Canada, Inc.Phenyl heterocycles as cox-2 inhibitors
US5521213A (en)1994-08-291996-05-28Merck Frosst Canada, Inc.Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
US5552422A (en)1995-01-111996-09-03Merck Frosst Canada, Inc.Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
AU5276696A (en)1995-04-041996-10-23Glaxo Group LimitedImidazo{1,2-a}pyridine derivatives
JPH11507669A (en)1995-06-121999-07-06ジー.ディー.サール アンド カンパニー Treatment of inflammation and inflammation-related diseases with a combination of cyclooxygenase-2 inhibitor and leukotriene B (4) receptor antagonist
US6136839A (en)*1995-06-122000-10-24G. D. Searle & Co.Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
US5700816A (en)*1995-06-121997-12-23Isakson; Peter C.Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
FR2757059B1 (en)1996-12-121999-01-29Rhone Poulenc Rorer Sa NEW THERAPEUTIC APPLICATION OF PYRROLE DERIVATIVES
FR2757166B1 (en)*1996-12-121999-01-29Rhone Poulenc Rorer Sa PYRROLE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CA2294057A1 (en)1997-06-131998-12-17Smithkline Beecham CorporationNovel pyrazole and pyrazoline substituted compounds
ES2203985T3 (en)1997-09-052004-04-16Glaxo Group Limited DERIVATIVES OF 2,3-DIARIL-PIRAZOLO (1,5) PIRIDAZINE, ITS PREPARATION AND ITS USE AS INHIBITORS OF CYCLLOXYGENASE 2 (COX-2) `.
AU3859999A (en)1998-05-141999-11-29G.D. Searle & Co.1,5-diaryl substituted pyrazoles as p38 kinase inhibitors
US6245789B1 (en)1998-05-192001-06-12The Procter & Gamble CompanyHIV and viral treatment
FR2779724B1 (en)1998-06-102001-04-20Rhone Poulenc Rorer Sa PYRROLE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE275148T1 (en)1998-11-032004-09-15Glaxo Group Ltd PYRAZOLOPYRIDINE DERIVATIVES AS SELECTIVE COX-2 INHIBITORS
WO2000052008A1 (en)1999-02-272000-09-08Glaxo Group LimitedPyrazolopyridines
DE60008382T2 (en)1999-06-282004-12-02Janssen Pharmaceutica N.V. RESPIRATORY SYNCYTIAL VIRUS REPLICATION INHIBITORS
GB9919778D0 (en)1999-08-211999-10-27Zeneca LtdChemical compounds
PE20020506A1 (en)2000-08-222002-07-09Glaxo Group Ltd PIRAZOLE DERIVATIVES FUSED AS PROTEIN KINASE INHIBITORS
AUPQ969800A0 (en)2000-08-282000-09-21Fujisawa Pharmaceutical Co., Ltd.Pyrazolopyridine compound and pharmaceutical use thereof
AU2002239348A1 (en)2000-12-152002-06-24Glaxo Group LimitedPyrazolopyridine derivatives
ATE301653T1 (en)2000-12-152005-08-15Glaxo Group Ltd PYRAZOLOPYRIDINES
GB0103926D0 (en)2001-02-172001-04-04Astrazeneca AbChemical compounds
EP1372642A1 (en)*2001-03-302004-01-02SmithKline Beecham CorporationUse of pyrazolopyridines as therapeutic compounds
ATE296826T1 (en)*2001-04-272005-06-15Smithkline Beecham Corp PYRAZOLO(1,5)PYRIDINE DERIVATIVES
CA2450555A1 (en)2001-06-252003-01-03Merck & Co., Inc.(pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds
CA2509085C (en)*2002-12-122012-06-19Shell Canada LimitedBore hole tool assembly, bearing system for use in such a bore hole tool assembly, and method of designing such a bore hole tool assembly

Also Published As

Publication numberPublication date
ES2243579T3 (en)2005-12-01
EP1377573B1 (en)2005-07-27
ATE300541T1 (en)2005-08-15
WO2002048148A2 (en)2002-06-20
JP2004515550A (en)2004-05-27
EP1377573A2 (en)2004-01-07
DE60112330T2 (en)2006-04-13
US20070287721A1 (en)2007-12-13
DE60112330D1 (en)2005-09-01
WO2002048148A3 (en)2003-05-01
US7163940B2 (en)2007-01-16
US20050049259A1 (en)2005-03-03

Similar Documents

PublicationPublication DateTitle
AU2002239344A1 (en)Pyrazolopyridines
AU2002239348A1 (en)Pyrazolopyridine derivatives
AU2002305143A1 (en)Pyrazolo'1,5-a!pyridine derivatives
AU2003228770A1 (en)Substituted pyrazolopyrimidines
DE602004021472D1 (en)Pyrimiidinverbindungen
PL366198A1 (en)Novel compounds
MXPA02012033A (en)2-aminocarbonyl-9h-purine derivatives.
MY134892A (en)Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA02012271A (en)Novel compounds possessing antibacterial, antifungal or antitumor activity.
ATE332301T1 (en) ANTIVIRAL PYRAZOLOPYRIDINE COMPOUNDS
IL158667A0 (en)Imidazo [1,2-a] pyridine derivatives for the prophylaxis and treatment of herpes viral infections
AU2001264474A1 (en)Admantane derivatives
MXPA04004498A (en)N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation.
WO2004100865A3 (en)New benzimidazole derivatives
AU2003217712A1 (en)Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
AU2002357740A1 (en)Pyrazolo-pyridine derivatives as antiherpes agents
AU2002248531A1 (en)Pyrazolopyriadine derivatives
WO2004087652A3 (en)Imidazotriazine compounds
PT1427417E (en)3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents
MXPA02012426A (en)Novel compounds.
WO2003080631A3 (en)Plasma carboxypeptidase b inhibitors
SE9904128D0 (en) Novel compounds
YU82302A (en)2-aminocarbonyl-9h-purine derivatives
TWI231815B (en)Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents

[8]ページ先頭

©2009-2025 Movatter.jp